Abstract Body

Genotypic testing (GT) is recommended by Public Health Service treatment guidelines and used as part of routine HIV surveillance to assess trends in HIV drug resistance and transmission patterns. Despite increasing rates of linkage to care (LTC), GT ≤90 days post diagnosis remains stable around 50%. This analysis aims to identify and address barriers to timely GT among persons who have successfully LTC.

Data were extracted from Philadelphia’s Enhanced HIV/AIDS Reporting System on individuals aged >18+ newly diagnosed with HIV from 2013-2015 and LTC within 90 days of diagnosis. LTC was defined as having a viral load (VL) or CD4 < 90 days after diagnosis. Multivariable logistic regression models predicted timely GT, defined as GT < 90 days of diagnosis. Models were adjusted for race, sex at birth, age at diagnosis, exposure category, type of diagnosing facility (testing/linkage site, outpatient medical facility, inpatient facility, correctional facility, other), year of diagnosis, insurance status, concurrent HIV/AIDS diagnosis, LTC within 30 days, and viral suppression (VS, defined as a VL <200 copies/ml at the last measure in the year after diagnosis).

1,383 Philadelphia residents that LTC < 90 days of diagnosis were included in the analysis. Of these, 56% received timely GT. New diagnoses aged 45+ were less likely to have evidence of timely GT compared to diagnoses aged 18-24 (AOR, 0.6; 95% CI:0.4-0.8). Those diagnosed at correctional facilities (AOR,0.4; 95% CI:0.2-0.7), inpatient facilities (AOR, 0.5; 95% CI:0.3-0.8), and outpatient medical facilities (AOR, 0.6; 95% CI:0.4-0.9) were all less likely to have timely GT compared to those diagnosed at testing and linkage sites. Individuals without insurance at diagnosis were 45% less likely to have timely GT compared to privately insured individuals (AOR, 0.5; 95%CI:0.4-0.8) Individuals who achieved VS within 1 year post diagnosis were 1.6 times as likely to have received timely GT as those who did not (95%CI:1.3-2.0).

Our data show poor adherence to recommendations for baseline GT in persons newly diagnosed with HIV. Timely GT is critical in improving long term care outcomes and in creating local transmission networks that provide entry points for intervention to reduce new HIV infections, both in keeping with National HIV/AIDS Strategy efforts. Age, insurance status, diagnosing facility, and VS are all factors that should be considered when targeting efforts to increase GT at the patient and provider level.